This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| ReAct Group | |
|---|---|
| Name | ReAct Group |
| Type | Non-profit network |
| Founded | 2014 |
| Headquarters | Oslo |
| Region served | Global |
| Key people | Anders B. Skovgaard; Anna C. Petersen; Marie L. Sørensen |
| Focus | Antimicrobial resistance; public health; research translation |
ReAct Group is an international network focused on combating antimicrobial resistance through policy advocacy, research synthesis, and capacity building. Founded by a coalition of clinicians, researchers, and civil society actors, the Group operates across multiple regions to influence policy processes and implementation at national and international levels. Its work intersects with a wide range of health institutions, research centers, and multilateral agencies.
ReAct Group emerged in the context of rising attention to antimicrobial resistance following high-profile reports by World Health Organization, Food and Agriculture Organization of the United Nations, and World Organisation for Animal Health. Early collaborators included actors from Oslo University Hospital, Karolinska Institutet, London School of Hygiene & Tropical Medicine, and University of Oxford. The Group engaged with landmark processes such as the Global Action Plan on Antimicrobial Resistance and dialogues involving the United Nations General Assembly, G7 summit, and G20 summit. Key historical events shaped its trajectory: engagement during the Ebola virus epidemic in West Africa (2014–2016), participation in consultations around the International Health Regulations (2005), and contributions to discussions at Wellcome Trust convenings and the Rockefeller Foundation forums.
The Group's mission emphasizes evidence-informed policy influencing actors such as World Health Organization, European Commission, African Union, and national ministries of health. Activities include producing policy briefs, systematic evidence syntheses with partners like Cochrane Collaboration and European Medicines Agency, and advocacy directed at bodies such as United Nations Environment Programme and Organisation for Economic Co-operation and Development. ReAct Group engages with academic institutions including Harvard T.H. Chan School of Public Health, Johns Hopkins Bloomberg School of Public Health, and Imperial College London to translate research for stakeholders like Bill & Melinda Gates Foundation and Wellcome Trust.
The Group is organized as a distributed secretariat with thematic leads in collaboration with regional hubs in Sub-Saharan Africa, South Asia, and Southeast Asia. Governance involves a steering committee with representatives from institutions such as Norwegian Directorate of Health, Public Health England, National Institutes of Health (United States), and civil society groups similar to Médecins Sans Frontières. Advisory input is sought from experts affiliated with University of Cape Town, Centre for Disease Dynamics, Economics & Policy, and National Center for Infectious Diseases (Singapore). Funding and oversight intersect with trusts and foundations like Open Society Foundations, Wellcome Trust, and governmental donors including Norwegian Ministry of Foreign Affairs and Swedish International Development Cooperation Agency.
Major programs target surveillance strengthening, stewardship, and One Health approaches. Surveillance initiatives align with platforms such as Global Antimicrobial Resistance Surveillance System and laboratory networks like European Centre for Disease Prevention and Control. Stewardship programs collaborate with hospital partners including Aga Khan University Hospital, Mayo Clinic, and Karolinska University Hospital to develop clinical guidance consistent with standards from World Health Organization and Clinical and Laboratory Standards Institute. One Health projects involve partnerships with Food and Agriculture Organization of the United Nations and veterinary research centers such as Royal Veterinary College and Veterinary Research Institute (Poland). Capacity building includes training modules co-created with London School of Hygiene & Tropical Medicine, University of Copenhagen, and Australian National University.
ReAct Group maintains formal and informal collaborations with multilateral organizations, academia, and non-governmental entities. Key partners include World Health Organization, United Nations Environment Programme, Food and Agriculture Organization of the United Nations, Wellcome Trust, and Bill & Melinda Gates Foundation. Academic collaborations span Karolinska Institutet, University of Oxford, Harvard University, Johns Hopkins University, and University of São Paulo. Civil society and implementation partners include Médecins Sans Frontières, Clinton Health Access Initiative, PATH (organization), and regional networks such as Africa Centres for Disease Control and Prevention. The Group has engaged with regulatory bodies like European Medicines Agency and U.S. Food and Drug Administration on policy dialogues.
ReAct Group’s contributions have featured in policy documents by World Health Organization and regional strategies adopted by European Commission and African Union. Its evidence syntheses have informed guidelines at institutions like National Institute for Health and Care Excellence and Centers for Disease Control and Prevention (United States). Recognition includes invitations to present at forums such as World Economic Forum, United Nations General Assembly side events, and symposia hosted by Wellcome Trust and Rockefeller Foundation. The Group’s influence is visible in national antimicrobial action plans endorsed by ministries across Europe, Africa, and Asia and in technical collaborations with laboratories affiliated to Pasteur Institute and Statens Serum Institut.